Programmable Delivery of Fluoxetine via Wearable Bioelectronics for Wound Healing In Vivo
Houpu Li,Hsin‐ya Yang,Narges Asefifeyzabadi,Prabhat Baniya,Andrea Medina Lopez,Anthony Gallegos,Kan Zhu,Tiffany Nguyen,Cristian Hernandez,Ksenia Zlobina,Cynthia Recendez,Hao‐Chieh Hsieh,Maryam Tebyani,Héctor Carrión,John Selberg,Le Luo,Moyasar A. Alhamo,Alexie Barbee,Jonathan Orozco,Cathleen Hsieh,Athena M. Soulika,Michael Levin,Narges Norouzi,Marcella Gomez,Min Zhao,Mircea Teodorescu,Roslyn Rivkah Isseroff,Marco Rolandi
DOI: https://doi.org/10.1002/admt.202301115
IF: 6.8
2024-02-07
Advanced Materials Technologies
Abstract:A programmable battery powered bioelectronic device delivers fluoxetine in a murine model for wound healing. The ability to deliver drugs with precise dosages at specific time points can significantly improve disease treatment while reducing side effects. Drug encapsulation for gradual delivery has opened the doors for a superior treatment regimen. To expand on this ability, programming bioelectronic devices to deliver small molecules enables ad‐hoc personalized therapeutic profiles that are more complex than gradual release. Here, a wearable bioelectronic device with an integrated electrophoretic ion pump that affords on‐demand drug delivery with precise dose control is introduced. Delivery of fluoxetine to wounds in mice result in a 27.2% decrease in the macrophage ratio (M1/M2) and a 39.9% increase in re‐epithelialization, indicating a shorter inflammatory phase and faster overall healing. Programmable drug delivery using wearable bioelectronics in wounds introduces a broadly applicable strategy for the long‐term delivery of a prescribed treatment regimen with minimal external intervention.
materials science, multidisciplinary